Sight Sciences (SGHT) Liabilities and Shareholders Equity (2020 - 2026)

Sight Sciences' Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $109.7 million for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 15.41% year-over-year to $109.7 million in Q1 2026; TTM through Mar 2026 was $463.2 million, a 18.13% decrease from a year earlier, with the FY2025 full-year figure at $115.3 million, down 19.28% from the prior year.
• Liabilities and Shareholders Equity eased to $109.7 million in Q1 2026 per SGHT's latest filing, from $115.3 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $258.6 million in Q1 2022 and bottomed at $109.7 million in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $155.6 million (2024), against an average of $167.5 million.
• Across the five-year window, Liabilities and Shareholders Equity soared 358.48% in 2022 and decreased 23.96% in 2023, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $213.1 million in 2022, then dropped by 21.79% to $166.7 million in 2023, then retreated by 14.29% to $142.8 million in 2024, then retreated by 19.28% to $115.3 million in 2025, then declined by 4.86% to $109.7 million in 2026.
• Per Business Quant, the three latest SGHT Liabilities and Shareholders Equity figures stand at $109.7 million (Q1 2026), $115.3 million (Q4 2025), and $116.3 million (Q3 2025).